Related Experiment Videos
Disulfide bonding controls the processing of retroviral envelope glycoproteins
B C Gliniak1, S L Kozak, R T Jones
1Department of Biochemistry and Molecular Biology, School of Medicine, Oregon Health Sciences University, Portland 97201-3098.
Abstract:
The mitogenic membrane glycoprotein (gp55) encoded by Friend erythroleukemia virus is inefficiently processed from the rough endoplasmic reticulum (RER) and only 3-5% reaches plasma membranes. Because this processed component (gp55P) contains larger and more complex oligosaccharides, it can be separated from RER gp55. In nonreducing conditions, gp55P is a unique disulfide-bonded dimer, whereas RER gp55 consists of monomers and dimers with diverse intrachain and interchain disulfide bonds. This suggests that gp55 folds heterogeneously and that only one homodimer is competent for export from the RER. Pulse-chase analyses of gp55 components labeled with radioactive amino acids indicated that formation of diverse disulfide-bonded components occurred within minutes of polypeptide synthesis and that malfolded components did not later isomerize to generate dimers competent for export from the RER. Chemical studies suggested that all 12 cysteines of gp55 were oxidized within 5 min after synthesis of the protein. In contrast, the envelope glycoprotein precursor (gPr90) encoded by a replication-competent murine leukemia virus folds more homogeneously, and it is then processed and cleaved to form an extracellular glycoprotein gp70 plus a transmembrane protein p15E. The fully processed glycoprotein contains an unoxidized cysteine sulfhydryl that isomerizes reversibly with a disulfide bond that links gp70 to p15E. Consequently, only a proportion of gp70 and p15E is disulfide-bonded, and dissociation occurs when the environment becomes even slightly reducing. The gp55 glycoprotein appears to be an extreme example of protein malfolding associated with imprecise and irreversible disulfide bonding. We discuss evidence that folding inefficiencies are common for retroviral proteins that have newly evolving pathogenic functions.
Insights
Friend erythroleukemia virus glycoprotein 55 (gp55) exhibits inefficient protein folding and disulfide bonding, hindering its transport from the endoplasmic reticulum. This malfolding is common in newly pathogenic retroviral proteins.
Area of Science:
- Retroviral protein processing
- Molecular biology of viral glycoproteins
- Protein folding and disulfide bond formation
Background:
- Friend erythroleukemia virus encodes a mitogenic membrane glycoprotein (gp55).
- gp55 is inefficiently processed from the rough endoplasmic reticulum (RER), with only 3-5% reaching plasma membranes.
- Processed gp55 (gp55P) has distinct oligosaccharides and disulfide bonding compared to RER gp55.
Purpose of the Study:
- To investigate the folding and disulfide bonding mechanisms of Friend erythroleukemia virus gp55.
- To compare gp55 processing with that of a replication-competent murine leukemia virus envelope glycoprotein precursor (gPr90).
- To explore the implications of protein malfolding in retroviral pathogenicity.
Main Methods:
- Pulse-chase analyses using radioactive amino acids to track gp55 synthesis and processing.
- Biochemical characterization of disulfide bond formation in gp55 and gPr90 under nonreducing and reducing conditions.
- Chemical analysis of cysteine oxidation in gp55.
Main Results:
- gp55 exhibits heterogeneous folding, with only specific homodimers competent for RER export.
- Diverse disulfide-bonded forms of RER gp55 arise rapidly after synthesis and do not isomerize to export-competent forms.
- gPr90 folds more homogeneously, with reversible disulfide bonding between its processed components (gp70 and p15E).
Conclusions:
- gp55 represents an extreme case of protein malfolding linked to irreversible disulfide bonding.
- Inefficient folding and imprecise disulfide bonding are likely common features of retroviral proteins with evolving pathogenic functions.
- Understanding these mechanisms is crucial for comprehending retroviral pathogenesis.